As of 2024-12-12, the Relative Valuation of Aptose Biosciences Inc (APS.TO) is (12.74) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.27 CAD, the upside of Aptose Biosciences Inc based on Relative Valuation is -4820.0%.
The range of the Relative Valuation is (17.37) - (4.54) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.1x - 10.7x | 8.9x |
| Forward P/E multiples | 1.2x - 1.9x | 1.6x |
| Fair Price | (17.37) - (4.54) | (12.74) |
| Upside | -6531.9% - -1780.2% | -4820.0% |
| Date | P/E |
| 2024-12-10 | -0.11 |
| 2024-12-09 | -0.12 |
| 2024-12-06 | -0.11 |
| 2024-12-05 | -0.11 |
| 2024-12-04 | -0.10 |
| 2024-12-03 | -0.11 |
| 2024-12-02 | -0.10 |
| 2024-11-29 | -0.10 |
| 2024-11-27 | -0.10 |
| 2024-11-26 | -0.10 |
| 2024-11-25 | -0.11 |
| 2024-11-22 | -0.11 |
| 2024-11-21 | -0.14 |
| 2024-11-20 | -0.15 |
| 2024-11-19 | -0.20 |
| 2024-11-18 | -0.20 |
| 2024-11-15 | -0.21 |
| 2024-11-14 | -0.23 |
| 2024-11-13 | -0.22 |
| 2024-11-12 | -0.22 |
| 2024-11-11 | -0.23 |
| 2024-11-08 | -0.22 |
| 2024-11-07 | -0.22 |
| 2024-11-05 | -0.22 |
| 2024-11-04 | -0.23 |
| 2024-11-01 | -0.22 |
| 2024-10-31 | -0.21 |
| 2024-10-30 | -0.23 |
| 2024-10-29 | -0.22 |
| 2024-10-28 | -0.20 |
| 2024-10-25 | -0.21 |
| 2024-10-23 | -0.23 |
| 2024-10-22 | -0.22 |
| 2024-10-21 | -0.23 |
| 2024-10-18 | -0.23 |
| 2024-10-17 | -0.20 |
| 2024-10-16 | -0.20 |
| 2024-10-15 | -0.20 |
| 2024-10-11 | -0.20 |
| 2024-10-10 | -0.20 |
| 2024-10-09 | -0.20 |
| 2024-10-08 | -0.20 |
| 2024-10-07 | -0.20 |
| 2024-10-04 | -0.20 |
| 2024-10-03 | -0.21 |
| 2024-10-02 | -0.22 |
| 2024-10-01 | -0.22 |
| 2024-09-30 | -0.22 |
| 2024-09-27 | -0.23 |
| 2024-09-26 | -0.23 |